A New Model For A New Era Of Psychedelic Therapy
MAPS Public Benefit Corporation hopes to kick off the next golden age of psychedelic therapy with the potential FDA approval of its MDMA candidate...
Stay updated with breaking news from Applied Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MAPS Public Benefit Corporation hopes to kick off the next golden age of psychedelic therapy with the potential FDA approval of its MDMA candidate...
(0) Centessa Pharmaceuticals ("Centessa") today announced that Antoine Yver, M.D., M.Sc., has been appointed as Chief Medical Officer. Dr. Yver is one of the world's leading drug developers with more than 30 years of global experience in the pharmaceutical industry. "We are absolutely thrilled to welcome Antoine to our team as CMO," said Saurabh Saha, M.D., Ph.D., Chief Executive Officer of Centessa. "Antoine is a true industry leader with significant experience and success as a drug developer, having developed some of the most impactful oncology drugs in the world. I look forward to partneri...